Literature DB >> 22241505

Cancer complementary and alternative medicine research at the US National Cancer Institute.

Libin Jia1.   

Abstract

The United States National Cancer Institute (NCI) supports complementary and alternative medicine (CAM) research which includes different methods and practices (such as nutrition therapies) and other medical systems (such as Chinese medicine). In recent years, NCI has spent around $120 million each year on various CAM-related research projects on cancer prevention, treatment, symptom/side effect management and epidemiology. The categories of CAM research involved include nutritional therapeutics, pharmacological and biological treatments, mind-body interventions, manipulative and body based methods, alternative medical systems, exercise therapies, spiritual therapies and energy therapies on a range of types of cancer. The NCI Office of Cancer Complementary and Alternative Medicine (OCCAM) supports various intramural and extramural cancer CAM research projects. Examples of these cancer CAM projects are presented and discussed. In addition, OCCAM also supports international research projects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22241505     DOI: 10.1007/s11655-011-0950-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  17 in total

1.  6-Shogaol is more effective than 6-gingerol and curcumin in inhibiting 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice.

Authors:  Hou Wu; Min-Chi Hsieh; Chih-Yu Lo; Cheng Bin Liu; Shengmin Sang; Chi-Tang Ho; Min-Hsiung Pan
Journal:  Mol Nutr Food Res       Date:  2010-09       Impact factor: 5.914

2.  Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy.

Authors:  Min Ye; Shwu-Huey Liu; Zaoli Jiang; Yashang Lee; Robert Tilton; Yung-Chi Cheng
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

3.  Effects of antioxidant herbs on chemotherapy-induced nausea and vomiting in a rat-pica model.

Authors:  Sangeeta R Mehendale; Han H Aung; Jun-Jie Yin; Elaine Lin; Anna Fishbein; Chong-Zhi Wang; Jing-Tian Xie; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2004       Impact factor: 4.667

4.  6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression.

Authors:  Min-Hsiung Pan; Min-Chi Hsieh; Jen-Min Kuo; Ching-Shu Lai; Hou Wu; Shengmin Sang; Chi-Tang Ho
Journal:  Mol Nutr Food Res       Date:  2008-05       Impact factor: 5.914

5.  Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells.

Authors:  Binghui Li; Chong-Zhi Wang; Tong-Chuan He; Chun-Su Yuan; Wei Du
Journal:  Cancer Lett       Date:  2009-08-27       Impact factor: 8.679

6.  Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer.

Authors:  Zhiqiang Meng; Peiying Yang; Yehua Shen; Wenying Bei; Ying Zhang; Yongqian Ge; Robert A Newman; Lorenzo Cohen; Luming Liu; Bob Thornton; David Z Chang; Zongxing Liao; Razelle Kurzrock
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

7.  Scutellaria baicalensis extract decreases cisplatin-induced pica in rats.

Authors:  Han H Aung; Lucy Dey; Sangeeta Mehendale; Jing-Tian Xie; Ji An Wu; Chun-Su Yuan
Journal:  Cancer Chemother Pharmacol       Date:  2003-08-27       Impact factor: 3.333

8.  Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.

Authors:  Brian T Kawasaki; Elaine M Hurt; Madhuri Kalathur; Maria Ana Duhagon; John A Milner; Young S Kim; William L Farrar
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

9.  Electroacupuncture attenuates bone-cancer-induced hyperalgesia and inhibits spinal preprodynorphin expression in a rat model.

Authors:  Rui-Xin Zhang; Aihui Li; Bing Liu; Linbo Wang; Jiajia Xin; Ke Ren; Jian-Tian Qiao; Brian M Berman; Lixing Lao
Journal:  Eur J Pain       Date:  2008-01-24       Impact factor: 3.931

10.  Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.

Authors:  Ena Wang; Scott Bussom; Jinguo Chen; Courtney Quinn; Davide Bedognetti; Wing Lam; Fulan Guan; Zaoli Jiang; Yichao Mark; Yingdong Zhao; David F Stroncek; Jeffrey White; Francesco M Marincola; Yung-Chi Cheng
Journal:  BMC Med Genomics       Date:  2011-05-11       Impact factor: 3.063

View more
  15 in total

1.  Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Authors:  Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W Engelman; Nagi Kumar; Jong Y Park
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

2.  Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years.

Authors:  Brittany C Kimball; Gail Geller; Rahma Warsame; Ashok Kumbamu; Aminah Jatoi; Barbara Koenig; Jon C Tilburt
Journal:  Oncologist       Date:  2018-03-09

3.  Acupuncture Improves Multiple Treatment-Related Symptoms in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.

Authors:  Hongjin Li; Judith M Schlaeger; Min Kyeong Jang; Yufen Lin; Chang Park; Tingting Liu; Min Sun; Ardith Z Doorenbos
Journal:  J Altern Complement Med       Date:  2021-08-27       Impact factor: 2.579

Review 4.  Treatment of Lung Cancer with Orally Administered Chinese Herbal Medicine: An Evidence Map between 1970-2020.

Authors:  Yue-Rong Gui; Ying Zhang; Xue-Qian Wang; Bing-Jie Fan; Jing-Lei Li; Lan-Xin Zhang; Fen Fan; Kang-di Cao; Xiao-Gang Zhang; Wei Hou
Journal:  Chin J Integr Med       Date:  2022-03-03       Impact factor: 2.626

Review 5.  Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese.

Authors:  Xun Li; Guoyan Yang; Xinxue Li; Yan Zhang; Jingli Yang; Jiu Chang; Xiaoxuan Sun; Xiaoyun Zhou; Yu Guo; Yue Xu; Jianping Liu; Alan Bensoussan
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

6.  Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival.

Authors:  Nagi B Kumar; Medha Dhurandhar; Bharat Aggarwal; Shrikant Anant; Kenyon Daniel; Gary Deng; Julie Djeu; Jinhui Dou; Ernest Hawk; B Jayaram; Libin Jia; Rajendra Joshi; Madhuri Kararala; Devarajan Karunagaran; Omer Kucuk; Lalit Kumar; Mokenge Malafa; G J Samathanam; Fazlul Sarkar; Maqsood Siddiqi; Rana P Singh; Anil Srivastava; Jeffrey D White
Journal:  Cancer Med       Date:  2013-02       Impact factor: 4.452

7.  Spica Prunellae extract inhibits the proliferation of human colon carcinoma cells via the regulation of the cell cycle.

Authors:  Wei Lin; Liangpu Zheng; Qunchuan Zhuang; Aling Shen; Liya Liu; Youqin Chen; Thomas J Sferra; Jun Peng
Journal:  Oncol Lett       Date:  2013-08-05       Impact factor: 2.967

8.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

9.  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Authors:  Nagi Kumar; Ganna Chornokur
Journal:  Transl Med (Sunnyvale)       Date:  2012-12-31

Review 10.  Mind-body therapies: evidence and implications in advanced oncology practice.

Authors:  Kelley D Mayden
Journal:  J Adv Pract Oncol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.